Not only did I read it, I cut and pasted my last post directly from it.
Regardless of the 6/7 patient ICS data, it clearly states that the presentation of the interim results from Phase 2b trials will cover PFS as well as safety data, so there's your first mistake.
It also gives the total trial enrollment as 63 patients, so there's your second mistake.
it also states that the triall enrollment was completed in September 2011.
Three strikes and your out!
recruitment for can003 trial phase, page-15
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.015(5.17%) |
Mkt cap ! $443.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.5¢ | 28.8¢ | $452.3K | 1.519M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 526593 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 201535 | 14 |
View Market Depth
| Last trade - 13.45pm 07/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |